Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Medical News

Antiretroviral Drugs Could Be Used to Prevent HIV Transmission, Study Says

February 7, 2008

Antiretroviral drugs might be effective at preventing the transmission of HIV, according to a study published online in the February issue of PLoS Medicine, the San Jose Mercury News reports (Johnson, San Jose Mercury News, 2/4). For the study, Jose Gerardo Garcia-Lerma of CDC and colleagues exposed five groups of macaques to SIV, the simian form of HIV, once a week for 14 weeks.

Researchers then gave four groups various dosages and combinations of Emtriva, or emtracitibine, and Viread, also known as tenofovir. The remaining group did not receive antiretrovirals (Joshi, ANI/Topnews, 2/5). One group received a daily injection of emtracitibine, which reduced the risk of HIV transmission by 3.8-fold compared with the control group. A second group received daily oral doses of both emtracitibine and tenofovir, which reduced the risk of transmission by 7.8-fold compared with the control group. A third group of macaques received daily injections of emtracitibine and higher doses of tenofovir before being exposed to SIV, and the fourth group received the same combination before and after exposure to the virus. Walid Heneine, a CDC researcher and co-author of the study, said the combination of emtracitibine and higher doses of tenofovir provided 100% protection against SIV.

"The findings from this intermittent study suggests that ultimately it is possible to provide a promising new avenue for future research, where it opens up the floor for a lot of more research for intermittent dosing," Heneine said (Berman, VOA News, 2/5). Heneine cautioned that the formulation the monkeys received contained more tenofovir compared with the version administered to humans. He added that it is too early to know if the combination could prevent HIV transmission among humans. According to the Mercury News, other studies to test if the combination could prevent HIV in humans are under way in the U.S. and several other countries (San Jose Mercury News, 2/4).

Advertisement
Online The study is available online.

Back to other news for February 2008


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2008 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News

Tools
 

Advertisement